Chemotherapy and target-related common adverse effects
In real life, for some cancer patients, chemotherapy is often a process of treatment that is necessary to prolong their lives. However, as we all know, there is a great deal of harm in this form of chemotherapy. So, what’s the negative effect of the chemo? Let’s get this straight! In clinical oncology treatment, neurotoxicity caused by anti-oncological chemotherapy drugs is generally the result of adverse effects of drugs that are common in clinical practice. This negative reaction occurs in part of the chemotherapy process. Severe neurotoxic effects usually lead to a situation in which the patient suffers from a reduction in the dose of chemotherapy drugs or even a withdrawal, while at the same time causing some damage to the patient ‘ s mental, physical and quality of life. The neurotoxicity induced by chemotherapy drugs is usually the central nervous system toxicity, in addition to which is the neurotoxicity of the outer rim and the sensory toxicity. Chemotherapy may cause gastrointestinal mucous membrane damage, followed by different levels of gastrointestinal adverse reaction. Patient stomach discomfort and vomiting, as well as lack of food, etc. If the condition is severe, it causes stomach pain, abdominal pain and vomiting, which can seriously affect the food intake of the patient, and may even induce hydrolytics and electrolytics, as well as acid imbalance, followed by severe malnutrition, etc., thereby reducing the quality of life of the patient. The immune system of cancer patients is in a state of marked disarray, loss of the ability to monitor cancer cells, misperceived cancer cells as part of themselves and allowed for their continued growth and rapid growth in the body. At the same time, chemotherapy has further destroyed the immune function of patients, resulting in a further decline in the immune function. It should be recalled that, after chemotherapy, cancer patients are vulnerable to serious infections, which can lead to an increase or even deterioration. Therefore, it is important to be careful to keep warm to prevent cold after chemotherapy. The fever after chemotherapy is one of the manifestations of the virus infection with low immunity. There are more likely to be adverse effects after target-to-pharmaceutical treatment, with adverse effects on skin, mucous membranes (e.g. rash, oral ulcer), digestive system (e.g. abdominal swelling, reduced appetite), cardiovascular system (e.g. high blood pressure, heart failure) and different patients. 1. Skin, mucous membrane adverse reactions: May have skin aching, rashes, oral ulcer, etc., and mucous membrane adverse reactions, which are more common in clinical settings and can be found in the treatment of drug targets such as Gifidini, Wimofini, Darafini, etc. 2. Indigent effects of digestive systems: There may be adverse effects of digestive systems such as abdominal swelling, nausea, reduced appetite, diarrhoea, etc., which are often less indigestion due to chemotherapy and are more likely to be mitigated after treatment. 3. Negative reaction of the cardiovascular system: There may be adverse reactions such as hypertension, haemorrhaging, heart failure, i.e. intravascular growth factor inhibitors such as Bavaria and Rigofini often lead to adverse reactions such as high blood pressure, haemorrhage, and ill reactions such as tratophos and Imatini target-oriented drugs can lead to reduced heart function, heart failure, etc. In addition to the above-mentioned adverse effects, there may be other adverse effects such as renal damage such as blood and protein urine and lung damage such as coughing and gas strangulation after the target drug treatment. Physical discomfort during the target drug treatment must be reported to the doctor in a timely manner, and he/she should actively cooperate with his/her assessment and treatment.
